The rupee devaluation has had a negative impact on the competitiveness of Pakistan’s pharmaceutical industry. The industry in Pakistan is local-market oriented due to significant barriers of entry to the export market. The devaluation makes pharma products less attractive to foreign purchasers. There are stringent regulations being placed by DRAP in terms of pricing which are somewhat affecting the industry adversely.
Pharmaceutical companies cannot meet their expenses from the current pricing structure because of which they are bound to demand an increase in price. These companies also have to import specific active pharma ingredients in order to manufacture medicine. This means it costs more to produce a pill in rupees which leads to lower margins and competitiveness in the market due to devaluation. The decrease and slowing down on the competition, however, is beneficial to the public, and to an extent, to the pharma industry. Therefore, having a rate which is feasible for both the industry and public is a better option.
Mehr Aftab
Toronto, Canada
Almost twice a year hunters visit Balochistan to trap rare birds. They sprawl over a vast area in Zhob, Lasbela, Killa...
There is a job crisis in the European Union as, according to some reports, employers are struggling to find applicants...
The newly-inducted government needs to make some critical decisions including privatizing or shuttering the bleeding...
One of the most prominent challenges facing Pakistan is the presence of corruption and nepotism, which undermines fair...
An alarming report from the World Health Organization indicates that Pakistan has the highest number of viral...
Climate change is the most important issue in today’s world. It has put a lot of countries at risk and the risk is...